329 related articles for article (PubMed ID: 28816144)
1. Comparison of Treatment Outcome Between Invasive Lobular and Ductal Carcinomas in Patients Receiving Partial Breast Irradiation With Intraoperative Electrons.
Leonardi MC; Maisonneuve P; Mastropasqua MG; Cattani F; Fanetti G; Morra A; Lazzari R; Bazzani F; Caputo M; Rotmensz N; Gerardi MA; Ricotti R; Enrica Galimberti V; Veronesi P; Dicuonzo S; Viale G; Jereczek-Fossa BA; Orecchia R
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):173-181. PubMed ID: 28816144
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes using accelerated partial breast irradiation in patients with invasive lobular carcinoma.
Shah C; Wilkinson JB; Shaitelman S; Grills I; Wallace M; Mitchell C; Vicini F
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e547-51. PubMed ID: 21640491
[TBL] [Abstract][Full Text] [Related]
3. Invasive lobular carcinoma of the breast: local recurrence after breast-conserving therapy by subtype approximation and surgical margin.
Braunstein LZ; Brock JE; Chen YH; Truong L; Russo AL; Arvold ND; Harris JR
Breast Cancer Res Treat; 2015 Jan; 149(2):555-64. PubMed ID: 25604797
[TBL] [Abstract][Full Text] [Related]
4. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial.
Veronesi U; Orecchia R; Maisonneuve P; Viale G; Rotmensz N; Sangalli C; Luini A; Veronesi P; Galimberti V; Zurrida S; Leonardi MC; Lazzari R; Cattani F; Gentilini O; Intra M; Caldarella P; Ballardini B
Lancet Oncol; 2013 Dec; 14(13):1269-77. PubMed ID: 24225155
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Survival Differences Between T1-2 Invasive Lobular Breast Cancer and Corresponding Ductal Carcinoma After Breast-Conserving Surgery: A Propensity-Scored Matched Longitudinal Cohort Study.
Wang K; Zhu GQ; Shi Y; Li ZY; Zhang X; Li HY
Clin Breast Cancer; 2019 Feb; 19(1):e101-e115. PubMed ID: 30502219
[TBL] [Abstract][Full Text] [Related]
6. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
Adachi Y; Ishiguro J; Kotani H; Hisada T; Ichikawa M; Gondo N; Yoshimura A; Kondo N; Hattori M; Sawaki M; Fujita T; Kikumori T; Yatabe Y; Kodera Y; Iwata H
BMC Cancer; 2016 Mar; 16():248. PubMed ID: 27015895
[TBL] [Abstract][Full Text] [Related]
7. Lumpectomy and radiation treatment for invasive lobular carcinoma of the breast.
Warneke J; Berger R; Johnson C; Stea D; Villar H
Am J Surg; 1996 Nov; 172(5):496-500. PubMed ID: 8942552
[TBL] [Abstract][Full Text] [Related]
8. Patients with invasive lobular breast cancer are less likely to undergo breast-conserving surgery: a population based study in the Netherlands.
Truin W; Roumen RM; Siesling S; van der Heiden-van der Loo M; Duijm LE; Tjan-Heijnen VC; Voogd AC
Ann Surg Oncol; 2015 May; 22(5):1471-8. PubMed ID: 25323475
[TBL] [Abstract][Full Text] [Related]
9. Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed.
Wazer DE; Schmidt-Ullrich RK; Ruthazer R; Schmid CH; Graham R; Safaii H; Rothschild J; McGrath J; Erban JK
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):851-8. PubMed ID: 9531370
[TBL] [Abstract][Full Text] [Related]
10. Clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC).
Biglia N; Maggiorotto F; Liberale V; Bounous VE; Sgro LG; Pecchio S; D'Alonzo M; Ponzone R
Eur J Surg Oncol; 2013 May; 39(5):455-60. PubMed ID: 23490334
[TBL] [Abstract][Full Text] [Related]
11. Re-excision rates of invasive ductal carcinoma with lobular features compared with invasive ductal carcinomas and invasive lobular carcinomas of the breast.
Arps DP; Jorns JM; Zhao L; Bensenhaver J; Kleer CG; Pang JC
Ann Surg Oncol; 2014 Dec; 21(13):4152-8. PubMed ID: 24980090
[TBL] [Abstract][Full Text] [Related]
12. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
Zhao H
Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
[TBL] [Abstract][Full Text] [Related]
13. Post-Mastectomy Radiation Therapy for Invasive Lobular Carcinoma: A Comparative Utilization and Outcomes Study.
Stecklein SR; Shen X; Mitchell MP
Clin Breast Cancer; 2016 Aug; 16(4):319-26. PubMed ID: 26943990
[TBL] [Abstract][Full Text] [Related]
14. The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology.
Moran MS; Yang Q; Haffty BG
Breast J; 2009; 15(6):571-8. PubMed ID: 19995377
[TBL] [Abstract][Full Text] [Related]
15. Multicenter Phase II Study of Intraoperative Radiotherapy of Early Breast Cancer: Ipsilateral Tumor Recurrence.
Sawaki M; Miyamoto T; Fujisawa T; Itoh Y; Ebara T; Tachibana H; Kodaira T; Kikumori T; Yanagita Y; Iwata H
Ann Surg Oncol; 2019 Aug; 26(8):2428-2434. PubMed ID: 30993410
[TBL] [Abstract][Full Text] [Related]
16. Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.
Metzger-Filho O; Ferreira AR; Jeselsohn R; Barry WT; Dillon DA; Brock JE; Vaz-Luis I; Hughes ME; Winer EP; Lin NU
Oncologist; 2019 Jul; 24(7):e441-e449. PubMed ID: 30518616
[TBL] [Abstract][Full Text] [Related]
17. Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? analysis of an institutional database over a 10-year period.
Fortunato L; Mascaro A; Poccia I; Andrich R; Amini M; Costarelli L; Cortese G; Farina M; Vitelli C
Ann Surg Oncol; 2012 Apr; 19(4):1107-14. PubMed ID: 21913022
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Outcomes of Once-Daily Accelerated Partial-Breast Irradiation With Tomotherapy: Results of a Phase 2 Trial.
de Paula U; D'Angelillo RM; Andrulli AD; Apicella G; Caruso C; Ghini C; Gomellini S; Ponti E; Pompei M; Caccavari A; Petrocchi A; Costarelli L; Giordano M; La Pinta M; Meli EZ; Mauri M; Minelli M; Rossi R; Scavina P; Broglia L; Ponzani T; Loreti A; Fortunato L
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):678-687. PubMed ID: 33098960
[TBL] [Abstract][Full Text] [Related]
19. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM
Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636
[TBL] [Abstract][Full Text] [Related]
20. Repeating conservative surgery after ipsilateral breast tumor reappearance: criteria for selecting the best candidates.
Gentilini O; Botteri E; Veronesi P; Sangalli C; Del Castillo A; Ballardini B; Galimberti V; Rietjens M; Colleoni M; Luini A; Veronesi U
Ann Surg Oncol; 2012 Nov; 19(12):3771-6. PubMed ID: 22618719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
